188 related articles for article (PubMed ID: 32858121)
21. The N-terminal non-RGS domain of human regulator of G-protein signalling 1 contributes to its ability to inhibit pheromone receptor signalling in yeast.
Somerville W; Song W; Kong JL; Panetta R; Greenwood MT
Cell Signal; 2003 Apr; 15(4):413-21. PubMed ID: 12618216
[TBL] [Abstract][Full Text] [Related]
22. RGS proteins: G protein-coupled receptors meet their match.
Chasse SA; Dohlman HG
Assay Drug Dev Technol; 2003 Apr; 1(2):357-64. PubMed ID: 15090201
[TBL] [Abstract][Full Text] [Related]
23. Regulators of G protein signaling proteins as targets for drug discovery.
Sjögren B; Blazer LL; Neubig RR
Prog Mol Biol Transl Sci; 2010; 91():81-119. PubMed ID: 20691960
[TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.
Velasco M; O'Sullivan C; Sheridan GK
Neuropharmacology; 2017 Feb; 113(Pt B):608-617. PubMed ID: 27059127
[TBL] [Abstract][Full Text] [Related]
25. Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signaling.
Neitzel KL; Hepler JR
Semin Cell Dev Biol; 2006 Jun; 17(3):383-9. PubMed ID: 16647283
[TBL] [Abstract][Full Text] [Related]
26. Emerging roles for RGS proteins in cell signalling.
Hepler JR
Trends Pharmacol Sci; 1999 Sep; 20(9):376-82. PubMed ID: 10462761
[TBL] [Abstract][Full Text] [Related]
27. RGS Redundancy and Implications in GPCR-GIRK Signaling.
Doupnik CA
Int Rev Neurobiol; 2015; 123():87-116. PubMed ID: 26422983
[TBL] [Abstract][Full Text] [Related]
28. Neuromodulators and therapeutic targets in neuropathic pain: from molecules to man.
Bermejo PE; Anciones B
CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):175-83. PubMed ID: 19601815
[TBL] [Abstract][Full Text] [Related]
29. Regulators of G protein signalling: a spotlight on emerging functions in the cardiovascular system.
Wieland T; Lutz S; Chidiac P
Curr Opin Pharmacol; 2007 Apr; 7(2):201-7. PubMed ID: 17276730
[TBL] [Abstract][Full Text] [Related]
30. The glutamatergic system as a target for neuropathic pain relief.
Osikowicz M; Mika J; Przewlocka B
Exp Physiol; 2013 Feb; 98(2):372-84. PubMed ID: 23002244
[TBL] [Abstract][Full Text] [Related]
31. Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief.
Moriconi A; Cunha TM; Souza GR; Lopes AH; Cunha FQ; Carneiro VL; Pinto LG; Brandolini L; Aramini A; Bizzarri C; Bianchini G; Beccari AR; Fanton M; Bruno A; Costantino G; Bertini R; Galliera E; Locati M; Ferreira SH; Teixeira MM; Allegretti M
Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16937-42. PubMed ID: 25385614
[TBL] [Abstract][Full Text] [Related]
32. Role and modulation of G protein-coupled receptor signaling in inflammatory processes.
Lombardi MS; Kavelaars A; Heijnen CJ
Crit Rev Immunol; 2002; 22(2):141-63. PubMed ID: 12433131
[TBL] [Abstract][Full Text] [Related]
33. Role of Regulators of G Protein Signaling Proteins in Bone Physiology and Pathophysiology.
Jules J; Yang S; Chen W; Li YP
Prog Mol Biol Transl Sci; 2015; 133():47-75. PubMed ID: 26123302
[TBL] [Abstract][Full Text] [Related]
34. RGS9 proteins facilitate acute tolerance to mu-opioid effects.
Garzón J; Rodríguez-Díaz M; López-Fando A; Sánchez-Blázquez P
Eur J Neurosci; 2001 Feb; 13(4):801-11. PubMed ID: 11207815
[TBL] [Abstract][Full Text] [Related]
35. How regulators of G protein signaling achieve selective regulation.
Xie GX; Palmer PP
J Mol Biol; 2007 Feb; 366(2):349-65. PubMed ID: 17173929
[TBL] [Abstract][Full Text] [Related]
36. Demethylation of G-Protein-Coupled Receptor 151 Promoter Facilitates the Binding of Krüppel-Like Factor 5 and Enhances Neuropathic Pain after Nerve Injury in Mice.
Jiang BC; Zhang WW; Yang T; Guo CY; Cao DL; Zhang ZJ; Gao YJ
J Neurosci; 2018 Dec; 38(49):10535-10551. PubMed ID: 30373770
[TBL] [Abstract][Full Text] [Related]
37. Targeting sensory neuron GPCRs for peripheral neuropathic pain.
Uniyal A; Tiwari V; Tsukamoto T; Dong X; Guan Y; Raja SN
Trends Pharmacol Sci; 2023 Dec; 44(12):1009-1027. PubMed ID: 37977131
[TBL] [Abstract][Full Text] [Related]
38. Mammalian RGS proteins: multifunctional regulators of cellular signalling.
Willars GB
Semin Cell Dev Biol; 2006 Jun; 17(3):363-76. PubMed ID: 16687250
[TBL] [Abstract][Full Text] [Related]
39. RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation. Precoupling and collision coupling.
Jaén C; Doupnik CA
J Biol Chem; 2006 Nov; 281(45):34549-60. PubMed ID: 16973624
[TBL] [Abstract][Full Text] [Related]
40. ErbB1-dependent signalling and vesicular trafficking in primary afferent nociceptors associated with hypersensitivity in neuropathic pain.
Mitchell R; Mikolajczak M; Kersten C; Fleetwood-Walker S
Neurobiol Dis; 2020 Aug; 142():104961. PubMed ID: 32531343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
